CoChat

The prognostic value of oncogenic antigen 519 (OA‐519) expression and proliferative activity detected by antibody MIB‐I in node‐negative breast cancer

Jensen, Vibeke, Ladekarl, Morten, Holm‐Nielsen, Peter, Melsen, Flemming, Sœrensen, Flemming Brandt · 1995 · The Journal of Pathology
Cited by 112

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The prognostic value of oncogenic antigen 519 (OA‐519) expression and tumour proliferative activity was evaluated in a retrospective series of 118 patients with low‐risk breast cancer. Low risk was defined as negative axillary nodes, tumour diameter ⩽50 mm, and no histological evidence of invasion of skin or deep fascia (=T 1 N 0 M 0 and T 2 N 0 M 0). The median follow‐up time was 104 months (range 5–143 months). Immunohistochemical analysis of OA‐519 expression was performed on formalin‐fixed, paraffin‐embedded tissue. The proliferative activity was estimated using a Ki‐67 equivalent monoclonal antibody (MIB‐1), which is applicable on formalin‐fixed, paraffin‐embedded tissue after microwave pretreatment. OA‐519 was expressed in about one‐third of the tumours and the percentage of proliferating cells (the MIB‐1 index) ranged between 1 and 72 per cent (median 17 per cent). Using multivariate Cox analysis, both the MIB‐1 index and OA‐519 expression were of independent prognostic value (2 p⩽0·01), and the combined immunohistological approach may therefore be useful in selecting patients with node‐negative breast cancer who might benefit from adjuvant therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/path.1711760405

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Jensen, V., Ladekarl, M., Holm‐Nielsen, P., Melsen, F., & Sœrensen, F. B.
Venue
The Journal of Pathology
Publisher
Wiley
Published
1995-08
Volume
176
Issue
4
Pages
343-352
ISSN
  • 0022-3417 (ISSN-L)
  • 1096-9896
OpenAlex
W1977658171
Cited by
112
References
3
FWCI
3.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.